Before the COVID-19 hit the globe by storm, various healthcare sectors focused on individual medical services. Today, the industry is aligning with public healthcare in an attempt to reduce the burden of the virus. Multiple medical professionals predict that the rising death toll will increase to the multimillion numbers by 2022. Besides putting off many procedures, patient outcomes are unfavorable and attention to prevailing issues is lower. Different countries are facing negative economic realities with the healthcare system under a crisis.
How has the healthcare sector done in 2020 with all the pandemic problems? COVID-19 has both positive and negative impacts on the healthcare industry.
The healthcare sector is performing negatively on the delivery of services to the patients and the provision of adequate safety resources for the staff. Both public and private entities often rely on insurance reimbursements to meet financial goals.
However, the coronavirus has caused billions of revenue losses due to low patient turnover. The stay-at-home safety guideline has led patients to post-pone procedures and self-quarantine in fear of contracting the virus. Also, more healthcare institutions are downsizing outpatient care; hence, failing and taking millions of employment opportunities away.
As the world healthcare sector is focusing on the COVID-19 pandemic, fatalities are increasing due to other preventable diseases. Kids are missing immunization against the routine health conditions and vaccination. The diagnosis of lifestyle diseases and other health conditions is low, causing more side effects and decreased life expectancy.
Rising stock market
Regardless of these losses, more investors are turning to healthcare stocks since they are available at the lowest prices. Pharmaceutical healthcare providers are experiencing increasing retail sales and mail-order deliveries. Life science research centers specializing in analytical products and services have also had an increase in demand.
Although such stock market changes are predictable amid the pandemic, insider trades are likely to prevail. However, the SEC is taking control of insider trading to instill transparency in the industry.
Adoption of advanced technology
The healthcare sector may have lagged in innovation, but the pandemic has forced the industry players to maintain steadfast technological growth. Most organizations are now using zoom video conferencing to hold meetings, training, and discuss the patient diagnosis.
What’s more, despite the delay in the services of pathology labs putting patients at a higher risk, COVID-19 tests have flooded the sector. With the increasing concern on the virus, more resources are now pulling to enhance control and prevention.
The media houses and the government are using advanced techniques and strategies for public awareness. These resources are aiming to sensitize the people towards safety measures and regulations. Telehealth, for example, allows medical institutions to conduct preventative care services for the safety of the patients and staff.
More healthcare organizations are shifting towards digital data transmission to maintain patient privacy and safety amid the pandemic. So, investing in upcoming but reliable medical discoveries could be reasonable.
What is a forecast for these kinds of stocks in 2021?
Regardless of the stable earnings of the healthcare stocks, 2021 is likely to experience some regulatory transformations. The development of the COVID-19 vaccine is also failing, and this is a downside to the healthcare stock.
Any investors looking to buy these stocks should, therefore, grab the discount opportunity this year. 2020 is experiencing the lowest mean month-end weighing in comparison to the previous years.
Health care experts are also recommending bailouts as small healthcare centers are collapsing and filing for bankruptcy. In case this proposal follows through and the dollars shift from insurance to fund the sector, this will directly affect the stock market.
Also, investing in insurance stocks in 2021 could lead to losses since the public needs a more affordable plan. The millennial, for instance, can’t afford the hundreds of monthly payments required for the available plans. Hence, look out for cheaper programs that include prescription and telehealth services.
Lastly, there is a rising concern surrounding the lack of expertise among healthcare professionals. To instill the best practices in the sector, the elevation of academic standards may be underway.
So, although the COVID-19 pandemic has had devastating effects on public health, it has shed some light on the problem areas. As such, investing in technology-driven stocks may be realistic as the sector strives to achieve improved patient health, safety, and privacy.
Some other articles you might find of interest:
Would you like to better understand how to drive and increase traffic to your startup website?
I am business grad with majors in Marketing and New Media, and I work as an independent marketing strategist. Writing is my passion as it gives me an opportunity to express myself. I love traveling and exploring the world, but most importantly, how the world is evolving.